Default company panoramic image
D70ab292 7b5c 44be 8141 6829b0083843

Microbial Medical, Inc.

Our novel imaging and therapeutic agents target bacterial infection utilizing proprietary sugars as carriers to focus existing medical compounds on bacteria.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Atlanta, GA, US
  • Currency USD
  • Founded January 2015
  • Employees 2
  • Website microbialmedical.com

Company Summary

We are launching novel imaging agents and drugs for diagnosing and treating bacterial and fungal infections, based on a platform technology for chemically linking existing medical compounds with sugars that pathogens consume and human cells reject. Our initial products are contrast agents that enable common medical scanners to image infection and antibiotics that address antibiotic resistance and have reduced toxicity.

Team

  • Over 20 years experience serving in executive management, entrepreneurial and management consulting roles, including McKinsey & Company
    Has founded or co-founded multiple entrepreneurial ventures, and served over 6 years as COO and CFO of QSpex Technologies, a VC-funded life sciences company
    MBA from Columbia Business School and a BBA (Honors) from The University of Georgia

  • Default avatar
    Michael Wach
    CEO

    Repeat entrepreneur
    Raised > $20M in VC
    Intellectual property expertise
    Expertise in in vivo molecular imaging
    Coulter Innovation and Entrepreneurship Award
    51 issued US patents
    BEE & MSEE, Ga. Tech.; Innovation & Entrepreneurship Program, Stanford University

Advisors